Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA)
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The main aim of this study is to compare the renal function (serum creatinine at 6 months) in
the later introduction of tacrolimus or rapamycin based in immunosuppressor regimes with
daclizumab, mycophenolate mofetil, and steroids in patients older than 50 years of age who
are the recipients of a graft from donors aged 55 years and older.
Phase:
Phase 4
Details
Lead Sponsor:
Sociedad Andaluza de Trasplantes de Organos y Tejidos